Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Pancreas Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03891784
What this trial is testing

Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

Who this might be right for
Advanced Digestive System Neuroendocrine NeoplasmDigestive System Neuroendocrine TumorForegut Neuroendocrine Tumor+6 more
University of Washington 20
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Not applicableUnknownNCT03443921
What this trial is testing

Divestment for Artery-involved Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic CancerNeoadjuvant Therapy+1 more
The First Affiliated Hospital with Nanjing Medical University 122
Not applicableStudy completedNCT03076216
What this trial is testing

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.

Who this might be right for
Unresectable Locally Advanced Pancreatic Carcinoma
OncoSil Medical Limited 9
Large-scale testing (Phase 3)Not Yet RecruitingNCT07656376
What this trial is testing

Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer With KRAS G12D Mutation

Who this might be right for
Pancreatic CancerPancreatic Carcinoma
Jiangxi Kvvit Pharmaceutical Co., Ltd. 465
Not applicableLooking for participantsNCT05191940
What this trial is testing

Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)

Who this might be right for
Pancreas Cancer
EBG MedAustron GmbH 30
Testing effectiveness (Phase 2)Looking for participantsNCT07444541
What this trial is testing

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Anova Innovation Limited 84
Not applicableUnknownNCT04310553
What this trial is testing

An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined With Radiotherapy and Chemotherapy in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic Caner
RenJi Hospital 240
Not applicableWithdrawnNCT02851381
What this trial is testing

Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05411094
What this trial is testing

Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CarcinomaStage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8+1 more
National Cancer Institute (NCI) 18
Not applicableNo Longer AvailableNCT03756311
What this trial is testing

Expanded Access to NanoPac

Who this might be right for
Locally Advanced Pancreatic CarcinomaProstate CancerLung Cancer
NanOlogy, LLC
Not applicableStudy completedNCT03469375
What this trial is testing

Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerChemotherapy EffectSurgery--Complications
Second Affiliated Hospital, Zhejiang University, School of Medicine 41
Testing effectiveness (Phase 2)Looking for participantsNCT06359275
What this trial is testing

PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients

Who this might be right for
Pancreatic Cancer
Fudan University 81
Early research (Phase 1)Study completedNCT00077519
What this trial is testing

Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Abramson Cancer Center at Penn Medicine 18
Early research (Phase 1)Ended earlyNCT00878657
What this trial is testing

Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Rutgers, The State University of New Jersey 8
Testing effectiveness (Phase 2)Study completedNCT00425841
What this trial is testing

Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Technical University of Munich 29
Testing effectiveness (Phase 2)UnknownNCT00024362
What this trial is testing

BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery

Who this might be right for
Pancreatic Cancer
Theradex
Testing effectiveness (Phase 2)Study completedNCT00597129
What this trial is testing

Safety and Efficacy Study of 90Y-hPAM4 at Different Doses

Who this might be right for
Pancreatic Cancer
Gilead Sciences 21
Large-scale testing (Phase 3)Study completedNCT01746979
What this trial is testing

Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma

Who this might be right for
Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma
ImmunoGenesis 693
Testing effectiveness (Phase 2)Active Not RecruitingNCT05736731
What this trial is testing

Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultSolid TumorPancreatic Cancer+13 more
A2 Biotherapeutics Inc. 160
Next Page